2023-08-11T18:00:10+00:00 2022-09-30 346565596 ERNST & YOUNG US LLP ONE MANHATTAN WEST NEW YORK NY 100018604 990 2021-10-01 043320640 Dana-FarberMass General Brigham Cancer Care INC DANA 6176323000 450 BROOKLINE AVE BP418 BOSTON MA 02215 RAMESH A SHIVDASANI MD PRESIDENT 6176323000 2023-08-11 true SALLY BOEMER 999009999 Nicole Sokolowski P01683199 2127733000 2023-07-31 2021 2023-04-26 12:10:37Z RAMESH A SHIVDASANI MD 450 BROOKLINE AVE BP418 BOSTON MA 02215 97184276 false X WWW.CANCERCARE.HARVARD.EDU X 1996 MA COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL AND BRIGHAM AND WOMEN'S HOSPITAL. 6 0 0 0 0 0 0 0 95108873 97123249 77495 61027 0 0 95186368 97184276 0 0 0 0 600518 640040 0 0 0 95418661 97147304 96019179 97787344 -832811 -603068 42647489 32590487 30899874 24571420 11747615 8019067 COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL, AND BRIGHAM AND WOMEN'S HOSPITAL. false false 97123249 0 97123249 CLINICAL TRIAL STUDIES AND RESEARCH RELATED TO INVESTIGATING NEW MEDICATIONS AND METHODS OF TREATMENT OF CANCER, WITH HOPE OF FINDING A CURE. 395529 0 0 EDUCATIONAL PROGRAMS FOR CLINICIANS AND RESEARCHERS WITH A FOCUS ON THE DF/MGH HEMATOLOGY ONCOLOGY FELLOWSHIP PROGRAM. 118914 0 0 DEVELOPMENT OF CLINICAL GUIDELINES, PROTOCOLS AND STANDARDS OF CARE FOR THE TREATMENT OF CANCER, AS WELL AS ESTABLISHING PRIORITIES FOR RESEARCH. 97637692 true false false false false false false false false false false false false true true true false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 0 0 0 false false false false false false false false false false false false X 6 0 false false false false true true true true true false false true true true true true true true false false MA X MELISSA CHAMMAS CO DFCI 6176323000 450 BROOKLINE AVE BP418 BOSTON MA 02215 Ramesh A Shivdasani MD PhD Trustee and President 2.0 48.0 X X 0 484168 43484 Bruce Johnson MD Trustee 1.0 49.0 X 0 671141 56584 David P Ryan MD Trustee 1.0 49.0 X 0 942912 61870 Jeffrey Meyerhardt MD PhD Trustee 1.0 49.0 X 0 488567 70862 Joseph Loscalzo MD PhD Trustee 1.0 49.0 X 0 898852 66010 Ravi I Thadhani MD MPH Trustee 1.0 49.0 X 0 1280098 63556 Hillary Mankin-Kufe ESQ Clerk (as of 3/28/22) 1.0 49.0 X 0 232569 17271 John Ryan ESQ Clerk (END 1/14/22) 1.0 49.0 X 0 617744 31945 Sally Mason Boemer Treasurer 1.0 49.0 X 0 1519675 63679 Edward J Benz JR MD Former Officer 0.0 50.0 X 0 2163654 51485 Laurie H Glimcher MD Former Officer 0.0 50.0 X 0 3672655 321403 Richard S Boskey ESQ Former Officer 0.0 50.0 X 0 799400 51348 0 13771435 899497 0 true true false Dana-Farber Cancer Institute Inc 450 Brookline Ave Boston MA 02115 Research Services 43583532 MASSACHUSETTS GENERAL HOSPITAL 399 Revolution Drive Ste 645 Somerville MA 02145 Research Services 38584505 BETH ISRAEL DEACONESS MEDICAL CENTER 110 Francis St BOSTON MA 02115 Research Services 3033089 BRIGHAM AND WOMEN'S HOSPITAL 399 Revolution Drive Ste 645 Somerville MA 02145 Research Services 2815898 BOSTON CHILDREN'S HOSPITAL 300 Longwood Ave BOSTON MA 02115 Research Services 519998 9 0 CLINICAL TRIALS/RESEARCH 621500 97123249 97123249 0 0 0 0 97123249 61027 61027 0 0 0 0 0 0 0 0 0 97184276 97123249 0 61027 X 0 0 512032 512032 128008 128008 21464 21464 97123248 97123248 0 0 2140 2140 MISCELLANEOUS 452 272 180 0 0 0 0 97787344 97637692 149652 0 27353102 23794479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9989 9990 0 0 0 0 11850471 8786018 0 0 0 0 3433927 0 42647489 32590487 29641 31000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 30870233 24540420 30899874 24571420 X 11747615 8019067 11747615 8019067 42647489 32590487 -603068 -3125480 0 X false true X true false X X 3 DANA-FARBER CANCER INSTITUTE INC 042263040 7 true 0 0 THE GENERAL HOSPITAL CORPORATION 042697983 3 true 0 0 BRIGHAM & WOMEN'S HOSPITAL 042312909 3 true 0 0 3 0 0 true false false false false false false false false false false false false false false false true Schedule A, Part I, Line 12g DANA-FARBER/MASS GENERAL BRIGHAM CANCER CARE, INC. ("DF/MGBCC, INC.") SUPPORTS ONLY DANA-FARBER CANCER INSTITUTE, INC., THE GENERAL HOSPITAL CORPORATION, AND BRIGHAM & WOMEN'S HOSPITAL. DF/MGBCC, INC. DOES NOT PROVIDE DIRECT MONETARY SUPPORT TO THESE ENTITIES. IN THIS SITUATION, DF/MGBCC, INC. PROVIDES SUPPORT FOR EDUCATIONAL PROGRAMS, CLINICAL TRIAL STUDIES, AND RESEARCH TO THE SUPPORTED ORGANIZATIONS. Schedule A, Part IV, Section B, Line 1 Power to elect or appoint PURSUANT TO DF/MGBCC, INC.'S ARTICLES OF ORGANIZATION, IT "IS ORGANIZED AND SHALL BE OPERATED EXCLUSIVELY FOR THE BENEFIT OF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ('BWH'), DANA-FARBER CANCER INSTITUTE, INC. ('DFCI'), AND THE GENERAL HOSPITAL CORPORATION ('MGH')". BWH, DFCI, AND MGH ARE PUBLICLY SUPPORTED ORGANIZATIONS WITHIN THE MEANING OF 26 USC § 509(A). UNDER DF/MGBCC, INC.'S BY-LAWS, DFCI AND MASS GENERAL BRIGHAM, INC., AS THE TWO CORPORATE MEMBERS OF DF/MGBCC, INC., HAVE THE POWER TO APPOINT AN EQUAL PROPORTION OF THE MEMBERS OF DF/MGBCC, INC.'S BOARD OF TRUSTEES. DF/MGBCC, INC. BENEFITS THE BWH, DFCI, AND MGH BY PERFORMING SERVICES IN CONNECTION WITH EDUCATION PROGRAMS, CLINICAL TRIALS, AND OTHER RESEARCH PROGRAMS FOR THE HOSPITALS. IN THIS WAY, DFCI AND MGB'S PURPOSES OF PROVIDING EXCELLENT MEDICAL CARE AND ENGAGING IN CRITICAL CANCER RESEARCH ARE SERVED BY THE SUPPORT THAT DF/MGBCC, INC. PROVIDES TO THE HOSPITALS. UNDER 26 CFR § 1.509(A)-4(G)(II), DF/MGBCC, INC. ISCONSIDERED TO BE "CONTROLLED BY" DFCI AND MGB WITHIN THE MEANING OF 26 USC § 509(A)(3)(B), EVEN THOUGH DF/MGBCC, INC. IS "OPERATED FOR THE BENEFIT OF" THE HOSPITALS WITHIN THE MEANING OF § 509(A)(3)(A). RESEARCH ADVANCES 24407065 Due to Participating Hospitals 133355 24540420 X 97184276 0 0 97184276 0 0 97184276 97787344 0 0 97787344 0 0 97787344 Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote THE CORPORATION IS A NOT-FOR-PROFIT CORPORATION AND IS TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. TAX-EXEMPT ORGANIZATIONS COULD BE REQUIRED TO RECORD AN OBLIGATION FOR INCOME TAXES AS THE RESULT OF A TAX POSITION THEY HAVE HISTORICALLY TAKEN ON VARIOUS TAX EXPOSURE ITEMS INCLUDING UNRELATED BUSINESS INCOME OR TAX STATUS. UNDER GUIDANCE ISSUED BY THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB), ASSETS AND LIABILITIES ARE ESTABLISHED FOR UNCERTAIN TAX POSITIONS TAKEN OR POSITIONS EXPECTED TO BE TAKEN IN INCOME TAX RETURNS WHEN SUCH POSITIONS ARE JUDGED TO NOT MEET THE "MORE-LIKELY-THAN-NOT" THRESHOLD, BASED UPON THE TECHNICAL MERITS OF THE POSITION. THE CORPORATION HAS EVALUATED THE POSITION TAKEN ON ITS FILED TAX RETURNS. THE CORPORATION HAS CONCLUDED NO UNCERTAIN INCOME TAX POSITIONS EXIST AT SEPTEMBER 30, 2022. false true false false false false false false false Ramesh A Shivdasani MD PhD Trustee and President 0 454900 0 1000 0 28268 0 33925 0 9559 0 527652 0 0 Bruce Johnson MD Trustee 0 562385 0 61447 0 47309 0 33113 0 23471 0 727725 0 0 Joseph Loscalzo MD PhD Trustee 0 690510 0 176504 0 31838 0 39263 0 26747 0 964862 0 0 Jeffrey Meyerhardt MD PhD Trustee 0 444194 0 24650 0 19723 0 33925 0 36937 0 559429 0 0 David P Ryan MD Trustee 0 803413 0 8083 0 131416 0 39261 0 22609 0 1004782 0 0 Ravi I Thadhani MD MPH Trustee 0 814477 0 378500 0 87121 0 31900 0 31656 0 1343654 0 0 Edward J Benz JR MD Former Officer 0 376204 0 1000 0 1786450 0 33925 0 17560 0 2215139 0 818568 Richard S Boskey ESQ Former Officer 0 610413 0 148600 0 40387 0 33925 0 17423 0 850748 0 0 Laurie H Glimcher MD Former Officer 0 1280223 0 212479 0 2179953 0 304525 0 16878 0 3994058 0 1191078 Sally Mason Boemer Treasurer 0 1039102 0 405033 0 75540 0 31900 0 31779 0 1583354 0 0 Hillary Mankin-Kufe ESQ Clerk (as of 3/28/22) 0 227311 0 1000 0 4258 0 15929 0 1342 0 249840 0 0 John Ryan ESQ Clerk (END 1/14/22) 0 606869 0 0 0 10875 0 0 0 31945 0 649689 0 0 Schedule J, Part I, Line 3 Arrangement used to establish the top management official's compensation PROCESS FOR DETERMINING COMPENSATION OF PRESIDENT: FOR FY22, THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF DFCI REVIEWS THE PERFORMANCE OF THE PRESIDENT AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO DFCI'S EXECUTIVE COMMITTEE, WHICH THEN APPROVES SUCH COMPENSATION. Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan THE FOLLOWING INDIVIDUALS PARTICIPATE IN 457(F) PLANS ESTABLISHED BY DFCI; TAXABLE AMOUNTS ARE INCLUDED IN REPORTABLE COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III): LAURIE H. GLIMCHER, MD $2,162,958 EDWARD J. BENZ, JR., MD $1,779,950 BRUCE JOHNSON, MD $29,099 RICHARD S. BOSKEY, ESQ $28,155 RAMESH A. SHIVDASANI, MD $17,484 Schedule J, Part II, Column (B)(iii) AND COLUMN C THE DEFERRED COMPENSATION AWARDS/OTHER BENEFITS FIGURE MAY INCLUDE AWARDS OF DEFERRED COMPENSATION, THE VALUE OF OTHER EMPLOYEE TAXABLE BENEFITS IN WHICH THE EMPLOYEE PARTICIPATES, SUCH AS LIFE INSURANCES, DEFERRED COMPENSATION PLANS, TUITION BENEFIT PLANS, HOUSING ALLOWANCES, AND THE VALUE OF NON-TAXABLE EMPLOYEE BENEFIT PLANS SUCH AS PENSION, GROUP HEALTH, LIFE, AND DISABILITY WHICH THE EMPLOYER PROVIDES TO EMPLOYEES ON A NON-DISCRIMINATORY BASIS AS REQUIRED BY THE IRS. NONE OF THE OFFICERS OR EMPLOYEES RECEIVE EXPENSE ACCOUNTS OR ALLOWANCES WHICH CONSTITUTE TAXABLE COMPENSATION. THE CORPORATION HAS AN "ACCOUNTABLE PLAN" WHICH PAYS FOR OR REIMBURSES EXPENSES ONLY IF THEY ARE "ORDINARY, NECESSARY, AND REASONABLE" EXPENSES "INCURRED FOR A BONA FIDE BUSINESS PURPOSE." THE CORPORATION CARRIES LIABILITY INSURANCE THAT COVERS ITS TRUSTEES AND OFFICERS. THIS INSURANCE COVERAGE PROVIDES AN INCIDENTAL BENEFIT TO THE COVERED INDIVIDUALS. Form 990, Part VI, Line 7a and Line 7B - POWER TO ELECT OR APPOINT GOVERNING BODY THE MEMBERS HAVE THE AUTHORITY TO ELECT OR APPOINT THE GOVERNING BODY OF DF/MGBCC, INC. CERTAIN GOVERNANCE DECISIONS RELATING TO SIGNIFICANT TRANSACTIONS, AMENDMENTS TO THE GOVERNING DOCUMENTS OF THE CORPORATION AND THE DISSOLUTION OF THE CORPORATION ARE RESERVED TO THE MEMBERS. Form 990, Part VI, Line 6 Classes of members or stockholders DANA-FARBER CANCER INSTITUTE, INC. ("DFCI") AND MASS GENERAL BRIGHAM, INC. ("MGB") ARE THE MEMBERS OF DANA-FARBER/MASS GENERAL BRIGHAM CANCER CARE, INC. ("DF/MGBCC, INC.") Form 990, Part VI, Line 11b Review of form 990 by governing body THE DANA-FARBER CANCER INSTITUTE TAX DEPARTMENT PROVIDES ALL FINANCIAL ANALYSIS AND OTHER INFORMATION TO BE INCLUDED ON THE TAX RETURN TO ITS EXTERNAL TAX PREPARER, ERNST & YOUNG LLP, WHICH PREPARES THE DRAFT RETURN. THE DRAFT RETURN IS REVIEWED BY THE TREASURER AND THE BOARD OF TRUSTEES. A FINAL VERSION OF THE FORM IS MADE AVAILABLE TO THE BOARD BEFORE FILING WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy DF/MGBCC, INC. HAS A WRITTEN CONFLICT OF INTEREST POLICY THAT IS CONSISTENT WITH THE IRS SAMPLE CONFLICT OF INTEREST POLICY. PER THE DF/MGBCC, INC. CONFLICT OF INTEREST POLICY, IN ORDER TO AVOID A CONFLICT OF INTEREST OR AN APPEARANCE OF A CONFLICT OF INTEREST A TRUSTEE SHOULD NOT PARTICIPATE IN A VOTE ON A TRANSACTION IN WHICH THE TRUSTEE OR FAMILY MEMBER HAS A FINANCIAL INTEREST AND SHOULD DISCLOSE ANY POTENTIAL CONFLICT BEFORE DF/MGBCC, INC. ACTS ON THE TRANSACTION. IF A DISCLOSURE WAS MADE, THE BOARD OF TRUSTEES WOULD INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION AND DETERMINE WHETHER A MORE ADVANTAGEOUS TRANSACTION THAT WOULD NOT GIVE RISE TO A CONFLICT WOULD BE REASONABLY ATTAINABLE. IF SUCH A TRANSACTION IS NOT ATTAINABLE, A TRANSACTION WITH A TRUSTEE, A MEMBER OF HIS OR HER FAMILY, OR AN ENTITY WITH WHICH ONE OR MORE OF THEM HAS A MATERIAL INTEREST, MAY BE APPROVED BY THE MAJORITY VOTE OF THE DISINTERESTED TRUSTEES. Form 990, Part VI, Line 15a Process to establish compensation of top management official FOR FY22, THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF DFCI REVIEWS THE PERFORMANCE OF THE PRESIDENT AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO DFCI'S EXECUTIVE COMMITTEE, WHICH THEN APPROVES SUCH COMPENSATION. Form 990, Part VI, Line 19 Required documents available to the public GOVERNING DOCUMENTS: WE CURRENTLY PROVIDE THE GOVERNING DOCUMENTS UPON REQUEST. THE ARTICLES OF ORGANIZATION ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY: DF/MGBCC, INC.'S CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS: AUDITED FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST. Form 990, Part VII, Section A line 1a THE INDIVIDUALS WHO HAVE COMPENSATION FROM RELATED ORGANIZATIONS IN COLUMN E SPEND THE REMAINDER OF THEIR FULL-TIME HOURS WORKING FOR DANA-FARBER CANCER INSTITUTE, INC. OR MASS GENERAL BRIGHAM, INC. AND ITS AFFILIATES. Form 990, Part IX, Line 11g Other Fees INST. SUPPORT - Total Expense: 97123248, Program Service Expense: 97123248, Management and General Expenses: 0, Fundraising Expenses: 0; DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BP418 BOSTON MA 02215 042603040 CANCER CARE MA 501(c)(3) 7 NA false THE GENERAL HOSPITAL CORPORATION 55 FRUIT STREET BOSTON MA 02215 042697983 HOSPITAL MA 501(c)(3) 3 NA false THE BRIGHAM & WOMEN'S HOSPITAL 75 FRANCIS STREET BOSTON MA 02215 042312909 HOSPITAL MA 501(c)(3) 3 NA false false false false false false false false false false false false false true false false false false false false DANA-FARBER CANCER INSTITUTE INC M 50143679 COST THE GENERAL HOSPITAL CORPORATION M 36663077 COST THE BRIGHAM AND WOMEN'S HOSPITAL M 5623322 COST